Is KK Shah Hospital overvalued or undervalued?
As of January 2, 2025, KK Shah Hospital is considered overvalued and risky due to negative earnings, poor return on equity, and unfavorable valuation metrics compared to its peers, alongside a lagging stock performance relative to the Sensex.
As of 2 January 2025, KK Shah Hospital's valuation grade has moved from fair to risky, indicating a significant deterioration in its financial outlook. The company appears to be overvalued based on its current metrics, with a PE ratio of -33.36, an EV to EBITDA of 32.56, and a Price to Book Value of 2.37. These ratios suggest that the market is pricing the stock at a premium despite its negative earnings and poor return on equity of -2.34%.In comparison to its peers, KK Shah Hospital's valuation stands out unfavorably. For instance, Max Healthcare Institute Ltd. has a PE ratio of 100.29, while Apollo Hospitals Enterprise Ltd. shows a PE of 69.03, both indicating a much stronger market position. Additionally, the company's recent stock performance has lagged behind the Sensex, with a 1-year return of -7.08% compared to the Sensex's 7.53%. Overall, KK Shah Hospital is considered overvalued relative to its financial performance and peer group.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
